Comments
Krebs Biochemicals & Industries has informed the exchanges that its board of directors on Monday approved raising of funds by way of an offer and issue of equity shares to the members of the company on rights basis for up to ₹25 crore. The right issue price and entitlement ratio will be decided later. However, the decision is subject to necessary approvals, the company said. Shares of Krebs Biochem jumped 5 per cent at ₹115.90 on the NSE, while it slipped 0.75 per cent at ₹118.75 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.